Journal
JOURNAL OF GASTROINTESTINAL ONCOLOGY
Volume 6, Issue 2, Pages 208-223Publisher
AME PUBLISHING COMPANY
DOI: 10.3978/j.issn.2078-6891.2014.077
Keywords
Immune system; immunotherapy; inflammation; colorectal cancer (CRC)
Categories
Funding
- American Society for Radiation Oncology (ASTRO)
- University of California Los Angeles Clinical and Translational Science Institute (UCLA CTSI)
Ask authors/readers for more resources
The development of cancer is a multi-step process involving the gradual loss of regulation over the growth and functional capabilities of normal cells. Much research has been focused on the numerous cell intrinsic factors that govern this process; however, recent attention has turned to understanding the cell extrinsic factors in the tumor microenvironment that appear equally critical to the progression and treatment of cancer. One critical component of the tumor microenvironment is the immune system and it has become increasingly evident that the immune system plays an integral role in preventing and promoting the development of cancer. Understanding the immune cell types and pathways involved in this process has enabled the development of novel biomarkers for prognosis and accelerated the development of immune-based therapeutics, both of which have the potential to forever change the treatment paradigms for colorectal cancer (CRC). In this review, we discuss the impact of the immune system on the initiation, progression and treatment of cancer, specifically focusing on CRC.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available